Home › Funds › ARS Investment Partners, LLC › BHVN
ARS Investment Partners, LLC position in BHVN
BIOHAVEN LTD · Health Care
ARS Investment Partners, LLC reported holding 1,372,668 shares of BHVN (BIOHAVEN LTD) in its Q3 2026 13F filing — a position valued at US$18.3M, representing 0.82% of its reported portfolio and ranking #34 among its reported holdings. ARS Investment Partners, LLC has disclosed BHVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ARS Investment Partners, LLC's BHVN position evolved
ARS Investment Partners, LLC first disclosed a stake in BHVN in Q3 2023 at 624,349 shares (US$16.2M). The position peaked in Q3 2024 at 1,030,239 shares, worth US$51.5M. Across 13 filings, ARS Investment Partners, LLC increased the stake 7 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 1,372,668 shares valued at US$18.3M. Notable position changes include a 48% increase in Q2 2024 (shares rose 44% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 624.35K | $16.24M | New |
| Q4 2023 | 633.96K | $27.13M | Add |
| Q1 2024 | 636.37K | $34.80M | Hold |
| Q2 2024 | 940.51K | $32.65M | Add |
| Q3 2024 | 1.03M | $51.48M | Add |
| Q4 2024 | 1.04M | $38.87M | Add |
| Q1 2025 | 1.04M | $38.84M | Hold |
| Q2 2025 | 1.19M | $16.76M | Add |
| Q3 2025 | 1.10M | $16.55M | Reduce |
| Q4 2025 | 1.24M | $14.00M | Add |
| Q1 2026 | 1.38M | $11.66M | Add |
| Q2 2026 | 1.37M | $20.45M | Hold |
| Q3 2026 | 1.37M | $18.33M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BHVN and 13F data
BHVN (BIOHAVEN LTD) is a Health Care company. 27 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BHVN
- MONTANOVA CAPITAL, LLC 10.29M sh · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M sh · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M sh · $43.70M · Q2 2026
- Cormorant Asset Management, LP 2.61M sh · $38.84M · Q2 2026
- Knoll Capital Management, LLC 2.35M sh · $35.01M · Q2 2026
- TCG Crossover Management, LLC 1.78M sh · $26.49M · Q2 2026
More on ARS Investment Partners, LLC
FAQ
How long has ARS Investment Partners, LLC held BHVN?
ARS Investment Partners, LLC has disclosed BHVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ARS Investment Partners, LLC's current position in BHVN?
As of Q3 2026, ARS Investment Partners, LLC holds 1.37M shares of BHVN (BIOHAVEN LTD), valued at $18.33M, representing 0.82% of its reported portfolio and ranking #34.
Has ARS Investment Partners, LLC been buying or selling BHVN?
In the latest 13F filing (Q3 2026), ARS Investment Partners, LLC held unchanged its position in BHVN. The position peaked in Q3 2024 at 1.03M shares.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.